Our Series C funding will help to launch our diagnostics business with exciting products in prostate cancer and insulin resistance.Metabolon offers global biochemical profiling (metabolomic) services to researchers working in drug safety and toxicology, bioprocess optimization, consumer products and other areas which benefit from insight into complex biochemical processes and how they change in